Skip to main navigation Skip to search Skip to main content

Hereditary pancreatic cancer

  • Derk C.F. Klatte
  • , Michael B. Wallace
  • , Matthias Löhr
  • , Marco J. Bruno
  • , Monique E. van Leerdam
  • Leiden University
  • Mayo Clinic Rochester, MN
  • Karolinska Institutet
  • Erasmus University Rotterdam
  • Netherlands Cancer Institute

Research output: Contribution to journalReview articlepeer-review

52 Scopus citations

Abstract

Pancreatic cancer is one of the deadliest malignancies. Therefore, there is an urgent need to detect pancreatic cancer in an earlier stage to improve outcomes. A variety of hereditary cancer syndromes have been associated with an increased risk of developing pancreatic cancer, and these individuals may benefit from surveillance programs. Surveillance programs have shown potential to improve outcomes, but have important risks such as overtreatment. In this review we will discuss the definitions and epidemiology of hereditary pancreatic cancer, recommendations for genetic testing and participation in surveillance. Important aspects are differences in surveillance strategies, target lesions, and potential benefits and harms of surveillance. Lastly we will highlight future directions for research and improvement of care for individuals at high-risk of pancreatic cancer.

Original languageEnglish
Article number101783
JournalBailliere's Best Practice and Research in Clinical Gastroenterology
Volume58-59
DOIs
StatePublished - 1 Jun 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Familial pancreatic cancer
  • Hereditary pancreatic cancer
  • High-risk individuals
  • Pancreatic ductal adenocarcinoma
  • Surveillance

Fingerprint

Dive into the research topics of 'Hereditary pancreatic cancer'. Together they form a unique fingerprint.

Cite this